Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinyouli vs rhG-CSF for chemotherapy-induced neutropenia in NSCLC
CTR20140861Phase 4Completed
- Sponsor
- Shandong Granberg Biopharmaceutical
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Shandong Granberg Biopharmaceutical. Started Dec 2014; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20140861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140861.